May 25, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory organ to the health minister, will discuss on June 5 whether to recommend approval of Eli Lilly Japan’s once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide. Dulaglutide,...read more